TumCP Cancer Research Results
TumCP, Tumor Cell proliferation: Click to Expand ⟱
| Source: |
| Type: |
Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors.
|
AML, Acute Myeloid Leukemia: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
TumCP↓, TOP1↓, TOP2↓,
eff↑, AntiThr↑, Bacteria↓, LDH↓, TumCP↓, TumCCA↑, Bcl-2↓, Cyt‑c↑, Casp3↑,
AntiTum↑, GlucoseCon↓, ROS↑, TumCP↓, eff↓, Glycolysis↓,
TumCP↓, OCR↓, ATP↓, TumCCA↑, ECAR↑, Glycolysis↓, lactateProd↓, mitResp↓,
| - |
in-vitro, |
AML, |
U937 |
|
|
|
- |
in-vitro, |
AML, |
THP1 |
|
|
|
Apoptosis↑, Casp7↑, PARP1↑, Bcl-2↓, Myc↓, CHOP/DDIT3↑, P21↑, p62↑, TumCCA↑, TXNIP↑, ROS↑, *antiOx↑, *Inflam↓, *neuroP↑, AntiCan↑, TumCP↓, angioG↓, TumMeta↓, VEGF↓, MMPs↓, tumCV↓, DNAdam↑, CHOP/DDIT3↑, cMyc↓, BioAv↓, Half-Life↓, BioAv↑,
TumCP↓, Apoptosis↑, ROS↑, NO↑, cl‑Bcl-2↑, BAX↑, MMP↓, Cyt‑c↑, AIF↑, Diablo↑, survivin↓, ICAD↓, Casp↑, cl‑PARP↑, DR4↑, TNFR 1↑,
| - |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Liver, |
Hep3B |
|
|
|
- |
in-vitro, |
AML, |
K562 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
TumCP↓, eff↑, other↝,
TumCP↓, TumCCA↑, TumCD↑, HSP90↓, HSP70/HSPA5↑, cycD1/CCND1↓, CDK4↓, CDK6↓, ATPase↓,
| - |
in-vitro, |
lymphoma, |
U937 |
|
|
|
- |
in-vitro, |
AML, |
Jurkat |
|
|
|
TumCP↓, selectivity↑, Apoptosis↑, TumCCA↑, DNAdam↑, eff↓, ROS↑, tumCV↓,
| - |
in-vitro, |
AML, |
U937 |
|
|
|
- |
in-vivo, |
AML, |
NA |
|
|
|
TumCP↓, Apoptosis↑, TumCG↓, PDK1 / PDPK1↓, cl‑PARP↑, Bcl-xL↓, Bcl-2↓, Beclin-1/ATG6↓, ATG3↓, PI3K↓, Akt↓, eff↑,
lactateProd↓, TumCP↓, eff↑, Glycolysis↓,
tumCV↓, TumCP↓, selectivity↑, NF-kB↓, IKKα↓, MAPK↓,
| - |
vitro+vivo, |
AML, |
THP1 |
|
|
|
- |
in-vitro, |
AML, |
AMJ13 |
|
|
|
- |
vitro+vivo, |
lymphoma, |
HBL |
|
|
|
TumCP↓, TumAuto↑, IL1↓, NLRP3↓, Apoptosis↑, mtDam↑, P53↑, LDH↓,
TumCP↓, Casp3↑,
TumCP↓, Apoptosis↑, selectivity↑,
TumCP↓, DNAdam↓, Casp3↑, MMP↓, eff↑, Apoptosis↑,
AhR↑, TumCP↓, selectivity↑, Bcl-2↓, Fas↑, P21↑, p27/CDKN1B↑, P53↓, CDK2↓,
Apoptosis↑, Diff↑, tumCV↓, TumCP↓, MMP↓, BAX↑, Bcl-2↓, Bcl-xL↓, Mcl-1↓, Cyt‑c↑, cl‑Casp3↑, cl‑Casp9↑, cl‑PARP↑, p‑MEK↑, p‑ERK↑, ROS↑, eff↓,
TumCP↓, Ferroptosis↑, IGF2BP3/IMP3/KOC↓, MDM2↓,
ROS↑, other↑, p‑ERK↑, TumCP↓,
TumCP↓, BAX↑, Casp3↑, Bcl-2↓,
Showing Research Papers: 1 to 21 of 21
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 21
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
IGF2BP3/IMP3/KOC↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
Ferroptosis↑, 1, ROS↑, 6,
Mitochondria & Bioenergetics(tgid=3) ⓘ
AIF↑, 1, ATP↓, 1, p‑MEK↑, 1, mitResp↓, 1, MMP↓, 3, mtDam↑, 1, OCR↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
cMyc↓, 1, ECAR↑, 1, GlucoseCon↓, 1, Glycolysis↓, 3, lactateProd↓, 2, LDH↓, 2, PDK1 / PDPK1↓, 1,
Cell Death(tgid=5) ⓘ
AhR↑, 1, Akt↓, 1, Apoptosis↑, 8, BAX↑, 3, Bcl-2↓, 6, cl‑Bcl-2↑, 1, Bcl-xL↓, 2, Casp↑, 1, Casp3↑, 4, cl‑Casp3↑, 1, Casp7↑, 1, cl‑Casp9↑, 1, Cyt‑c↑, 3, Diablo↑, 1, DR4↑, 1, Fas↑, 1, Ferroptosis↑, 1, ICAD↓, 1, MAPK↓, 1, Mcl-1↓, 1, MDM2↓, 1, Myc↓, 1, p27/CDKN1B↑, 1, survivin↓, 1, TNFR 1↑, 1, TumCD↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
AntiThr↑, 1, other↑, 1, other↝, 1, tumCV↓, 4,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↑, 2, HSP70/HSPA5↑, 1, HSP90↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
ATG3↓, 1, Beclin-1/ATG6↓, 1, p62↑, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↓, 1, DNAdam↑, 2, P53↓, 1, P53↑, 1, cl‑PARP↑, 3, PARP1↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK2↓, 1, CDK4↓, 1, cycD1/CCND1↓, 1, P21↑, 2, TumCCA↑, 5,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
Diff↑, 1, p‑ERK↑, 2, PI3K↓, 1, TOP1↓, 1, TOP2↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
ATPase↓, 1, MMPs↓, 1, TumCP↓, 21, TumMeta↓, 1, TXNIP↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, NO↑, 1, VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IKKα↓, 1, IL1↓, 1, NF-kB↓, 1,
Protein Aggregation(tgid=19) ⓘ
NLRP3↓, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
CDK6↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 1, eff↓, 3, eff↑, 5, Half-Life↓, 1, selectivity↑, 4,
Clinical Biomarkers(tgid=22) ⓘ
LDH↓, 2, Myc↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, AntiTum↑, 1,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 1,
Total Targets: 95
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Functional Outcomes(tgid=23) ⓘ
neuroP↑, 1,
Total Targets: 3
Scientific Paper Hit Count for: TumCP, Tumor Cell proliferation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:2 Cells:% prod#:% Target#:327 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page